4//SEC Filing
Patel Kinnari 4
Accession 0001140361-25-013253
CIK 0001281895other
Filed
Apr 9, 8:00 PM ET
Accepted
Apr 10, 4:07 PM ET
Size
6.7 KB
Accession
0001140361-25-013253
Insider Transaction Report
Form 4
Patel Kinnari
See Remarks
Transactions
- Purchase
Common Stock
2025-04-09$4.70/sh+21,099$99,165→ 26,774 total(indirect: By Spouse)
Holdings
- 444,103
Common Stock
- 104,927(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]On April 9, 2025, the Reporting Person's husband purchased 21,099 shares of Common Stock in a series of brokered transactions at prices ranging from $4.65 to $4.78 and a weighted average price per share of $4.70 (rounded to two decimal places), for an aggregate purchase price of approximately $99,157. The detailed breakdown of executed sales will be furnished upon request.
- [F2]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- [F3]The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001725929
Filing Metadata
- Form type
- 4
- Filed
- Apr 9, 8:00 PM ET
- Accepted
- Apr 10, 4:07 PM ET
- Size
- 6.7 KB